FIELD: medicine, pharmacy, pharmaceutical industry. SUBSTANCE: invention concerns medicinal forms comprising interferon preparations. Invention proposes gel containing interferon and vitamin E and including additionally methionine, benzoic acid, citric acid, ethyl alcohol, glycerol, human serum albumin, sodium carboxymethylcellulose, sodium tetraborate and water. Gel exhibits the more broad spectrum of therapeutic using, more degree of an antiviral activity as compared with that in prototype in equal doses of interferon. Preparation does not induce adverse effects. EFFECT: decreased cost, improved facility in using, enhanced activity and properties. 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| AGENT POSSESSING IMMUNOMODULATORY AND ANTIVIRAL ACTIVITY | 2015 |
|
RU2592201C1 |
| MEDICINAL PRODUCT BASED ON INTERFERON ALFA-2B HUMAN RECOMBINANT METHIONINE-FREE | 2022 |
|
RU2795854C1 |
| PROLONGED INTERFERON SOLUTION | 2004 |
|
RU2270692C1 |
| ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
| USE OF BENZYL BENZOATE FOR NEW PURPOSE AS ANTIMYCOTIC AGENT, PRODUCING AND USING ANTIMYCOTIC PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2573976C2 |
| AGENT POSSESSING BIOCIDAL ACTION | 2017 |
|
RU2673807C2 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| ALPHA-INTERFERON PREPARATION IN THE FORM OF STABLE AQUEOUS SOLUTION FOR INJECTIONS | 2004 |
|
RU2255729C1 |
| ANTIVIRUS AGENT WITH HUMAN LEUKOCYTIC HUMAN INTERFERON BASED ON CHITOSAN SUCCINATE | 2009 |
|
RU2404796C1 |
